Xvivo Perfusion AB (publ) (0RKL.L)
SEK 461.69
(1.25%)
SEK 461.69
(1.25%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.07 SEK | 395.16% |
| 2022 | 0.62 SEK | 121.43% |
| 2021 | 0.28 SEK | 117.39% |
| 2020 | -1.61 SEK | -947.37% |
| 2019 | 0.19 SEK | -60.42% |
| 2018 | 0.48 SEK | 92.0% |
| 2017 | 0.25 SEK | 257.14% |
| 2016 | 0.07 SEK | -70.83% |
| 2015 | 0.24 SEK | -4.0% |
| 2014 | 0.25 SEK | -39.02% |
| 2013 | 0.41 SEK | 1143.26% |
| 2012 | -0.04 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 2.72 SEK | 216.28% |
| 2024 Q1 | 0.72 SEK | -66.82% |
| 2024 Q2 | 0.86 SEK | 19.44% |
| 2023 Q4 | 2.17 SEK | 2762.8% |
| 2023 Q3 | 0.08 SEK | -67.04% |
| 2023 Q2 | 0.23 SEK | -52.08% |
| 2023 FY | - SEK | 395.16% |
| 2023 Q1 | 0.48 SEK | 1835.48% |
| 2022 Q2 | 0.26 SEK | 62.5% |
| 2022 FY | - SEK | 121.43% |
| 2022 Q4 | 0.02 SEK | -86.22% |
| 2022 Q3 | 0.18 SEK | -30.77% |
| 2022 Q1 | 0.16 SEK | -58.97% |
| 2021 Q4 | 0.39 SEK | 1092.37% |
| 2021 FY | - SEK | 117.39% |
| 2021 Q3 | -0.04 SEK | 87.32% |
| 2021 Q2 | -0.31 SEK | -247.62% |
| 2021 Q1 | 0.21 SEK | 130.88% |
| 2020 FY | - SEK | -947.37% |
| 2020 Q4 | -0.68 SEK | -33.33% |
| 2020 Q3 | -0.51 SEK | 15.0% |
| 2020 Q2 | -0.60 SEK | -340.0% |
| 2020 Q1 | 0.25 SEK | 449.65% |
| 2019 Q2 | 0.08 SEK | 772.27% |
| 2019 Q3 | 0.19 SEK | 137.5% |
| 2019 Q4 | -0.07 SEK | -137.63% |
| 2019 FY | - SEK | -60.42% |
| 2019 Q1 | -0.01 SEK | -106.26% |
| 2018 FY | - SEK | 92.0% |
| 2018 Q4 | 0.19 SEK | 4900.0% |
| 2018 Q3 | 0.00 SEK | -97.47% |
| 2018 Q2 | 0.15 SEK | 0.0% |
| 2018 Q1 | 0.15 SEK | -28.57% |
| 2017 Q1 | -0.00 SEK | 92.66% |
| 2017 Q2 | 0.04 SEK | 2205.26% |
| 2017 Q4 | 0.21 SEK | 1667.16% |
| 2017 FY | - SEK | 257.14% |
| 2017 Q3 | -0.01 SEK | -133.5% |
| 2016 Q2 | 0.07 SEK | 40.0% |
| 2016 Q3 | -0.02 SEK | -132.43% |
| 2016 Q4 | -0.03 SEK | -14.1% |
| 2016 FY | - SEK | -70.83% |
| 2016 Q1 | 0.05 SEK | -70.59% |
| 2015 Q2 | 0.05 SEK | 205.26% |
| 2015 Q4 | 0.17 SEK | 183.33% |
| 2015 Q3 | 0.06 SEK | 20.0% |
| 2015 Q1 | -0.05 SEK | -227.59% |
| 2015 FY | - SEK | -4.0% |
| 2014 Q1 | 0.09 SEK | -25.0% |
| 2014 FY | - SEK | -39.02% |
| 2014 Q2 | 0.04 SEK | -55.56% |
| 2014 Q3 | 0.07 SEK | 75.0% |
| 2014 Q4 | -0.01 SEK | -120.71% |
| 2013 Q2 | 0.09 SEK | -25.0% |
| 2013 Q3 | 0.08 SEK | -11.11% |
| 2013 FY | - SEK | 1143.26% |
| 2013 Q4 | 0.12 SEK | 50.0% |
| 2013 Q1 | 0.12 SEK | 400.0% |
| 2012 Q4 | -0.04 SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|